Skip to content

Mindfulness exercises reduce death anxiety and burnout in intensive care nurses

Xiang-Zi Ji, Jia-Yuan Zhang

Death Studies August 25, 2022 DOI: 10.1080/07481187.2022.2113480 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Nonrandomized study Peer reviewed
Sample size 66
Population ICU nurses
Intervention Mindfulness-based intervention
Duration 8-week intervention
Topics Anxiety Meditation
Key points At post-test, ICU nurses who received an 8-week tailored mindfulness-based intervention had significantly lower death anxiety and job burnout than nurses who received no intervention. The authors conclude that mindfulness-based intervention can reduce death anxiety and burnout in ICU nurses.

Abstract

Abstract Intensive care units (ICUs) nurses experience a high level of death anxiety. Interventions that reduce death anxiety are needed. We conducted a nonrandomized study with 66 ICU nurses. The 34 in the intervention group received an 8-week tailored mindfulness-based intervention and the 32 in the control group received no intervention. Both groups completed pre and post-tests of death anxiety and burnout. At post-test, the levels of death anxiety and job burnout in the intervention group were significantly lower than the control group. Mindfulness-based intervention can reduce the death anxiety level and burnout of ICU nurses.

Comparable studies

Other non-randomized and open-label trials on anxiety, most cited first.

Study Year Design Participants
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression Patients with treatment-resistant depression 2018 Clinical trial n = 20
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder Subjects with obsessive-compulsive disorder (OCD) 2006 Controlled clinical trial
Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder Subjects with DSM-IV-diagnosed treatment-resistant major depressive disorder 2010 Open-label trial n = 33
Emotions and brain function are altered up to one month after a single high dose of psilocybin. Healthy volunteers (7 female, 5 male) 2020 Open-label pilot study n = 12
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study Older long-term AIDS survivor (OLTAS) self-identified gay men with moderate-to-severe... 2020 Open-label study

Citations in the library

Cited by 4

Cites 7

and 2 more in the library

Explore topics